Oguzhan Atay, PhD
About Oguzhan Atay, PhD
Oguzhan Atay is the co-founder, CEO, and Board Chair of BillionToOne, a company he started with David Tsao, Ph.D.
Company
Oguzhan Atay co-founded BillionToOne alongside David Tsao, Ph.D. BillionToOne is a genomics technology company. The company focuses on developing precision diagnostics that utilize advanced molecular counting technology to provide accurate and accessible diagnostics for prenatal care and other areas of healthcare. Under Atay's leadership, the company has grown and expanded its range of diagnostic services.
Title
Oguzhan Atay serves as the Co-Founder, CEO, and Board Chair of BillionToOne. In his role, he is responsible for overseeing the company's strategic direction, operational activities, and long-term vision. He plays a pivotal role in steering the company towards achieving its goals in the field of precision diagnostics.
Education and Expertise
Oguzhan Atay holds a Ph.D. His academic background and expertise in the field of genomics and molecular diagnostics position him well to lead BillionToOne. His deep understanding of the science behind the technology allows him to drive innovation and ensure the company remains at the forefront of precision diagnostics.
Co-Founding BillionToOne with David Tsao
Oguzhan Atay co-founded BillionToOne with David Tsao, Ph.D. Their partnership brings together complementary skills and knowledge, which have been instrumental in developing and launching the company's products and services. Together, they have built the company on a foundation of scientific excellence and a commitment to improving patient outcomes.
Commitment to Lab Samples
Oguzhan Atay is deeply invested in the quality and accuracy of every sample that comes into the BillionToOne lab. This commitment ensures that the diagnostics provided by the company meet high standards of reliability and precision. His attention to detail and dedication to quality control is a cornerstone of the company's operational ethos.